Wellington, New Zealand

Paul Henry Teesdale-Spittle


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2002-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Henry Teesdale-Spittle: A Pioneer in Anticancer Research

Introduction: Paul Henry Teesdale-Spittle is an innovative inventor based in Wellington, New Zealand. He has made significant contributions to the field of cancer treatment through his groundbreaking research and inventions. With a total of two patents to his name, Teesdale-Spittle is recognized for his unique approach to developing new therapeutic compounds.

Latest Patents: Among his latest inventions is a patent concerning anthraquinone compounds capable of serving as anticancer agents. The patent describes anthraquinone compounds of a general formula, which includes specific groups and variations aimed at enhancing their effectiveness in cancer therapy. These compounds demonstrate promising properties as selective prodrugs that are bioreduced in hypoxic tumors, transforming into cytotoxic cyclic amine derivatives. These amines are not only cytotoxic but also can serve as alkylating agents with topoisomerase II inhibiting activities, positioning them as valuable tools in the fight against cancer.

Career Highlights: Throughout his career, Teesdale-Spittle has worked at esteemed institutions and companies that focus on innovative research and development. Notably, he has been associated with De Montfort University and Somanta Limited, where his research has intersected with advanced cancer therapeutics, enhancing the prospects for patients worldwide.

Collaborations: Teesdale-Spittle has also had the opportunity to collaborate with accomplished professionals in his field, including Gerard Andrew Potter and Laurence Hylton Patterson. These collaborations have not only enriched his research but have also contributed to the broader scientific community's understanding of effective cancer treatments.

Conclusion: Paul Henry Teesdale-Spittle exemplifies the spirit of innovation within the field of cancer research. His dedication to discovering new anticancer compounds highlights the essential role of inventors in advancing medical science. As he continues to develop novel therapeutic solutions, his contributions remain pivotal in the ongoing battle against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…